Daehan New Pharm
대한뉴팜 is a Korean pharmaceutical company offering human and veterinary medicines, biologics, health functional foods and medical devices. The website shows product catalogs across those categories and publishes corporate news covering R&D, facility investment, product launches, export activities and sales results.
Industries
Nr. of Employees
medium (51-250)
Products
Human pharmaceuticals
Prescription and over-the-counter medicines intended for human healthcare.
Veterinary pharmaceuticals
Medicines formulated for animal health and veterinary use.
Biologics
Biologic therapeutic products listed under a dedicated product category.
Export medicines
Pharmaceutical products intended for export markets.
Health functional foods
Products classified as health functional foods.
Medical devices
Medical device products offered via a product category on the site.
Human pharmaceuticals
Prescription and over-the-counter medicines intended for human healthcare.
Veterinary pharmaceuticals
Medicines formulated for animal health and veterinary use.
Biologics
Biologic therapeutic products listed under a dedicated product category.
Export medicines
Pharmaceutical products intended for export markets.
Health functional foods
Products classified as health functional foods.
Medical devices
Medical device products offered via a product category on the site.
Services
Manufacture and commercial distribution of medicines for human and animal use across multiple product categories.
Development and production services for biologic medicines as indicated by a biologics product category.
Activities to expand pharmaceutical exports including participation in international trade events.
Manufacture and commercial distribution of medicines for human and animal use across multiple product categories.
Development and production services for biologic medicines as indicated by a biologics product category.
Activities to expand pharmaceutical exports including participation in international trade events.
Expertise Areas
- Human pharmaceutical manufacturing and commercialization
- Veterinary pharmaceutical development and commercialization
- Biologics development and manufacturing
- Export and international business development
Key Technologies
- Biologics production
- Pharmaceutical formulation development
- Manufacturing for oral and injectable dosage forms
- Product commercialization and export operations
News & Updates
News item reporting participation in an international trade event and concurrent R&D and facility investment.
News item reporting increased demand for an injectable/infusion therapy product during influenza season.
Quarterly financial results reporting cumulative revenue and operating profit.
News item reporting quarterly sales figures.
News item announcing the launch of a veterinary fluconazole formulation.
Reported cumulative revenue of 151.2 billion KRW and operating profit of 14.9 billion KRW for a fiscal quarter.
News item reporting participation in an international trade event and concurrent R&D and facility investment.
News item reporting increased demand for an injectable/infusion therapy product during influenza season.
Quarterly financial results reporting cumulative revenue and operating profit.
News item reporting quarterly sales figures.
News item announcing the launch of a veterinary fluconazole formulation.
Reported cumulative revenue of 151.2 billion KRW and operating profit of 14.9 billion KRW for a fiscal quarter.